Name: BioNexus Gene Lab Corp. (BGLC) Balance Sheet
Creator: FinSpry

BioNexus Gene Lab Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for BioNexus Gene Lab Corp. (BGLC) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	4.38	5.93	0.61	0.58	0.70
Short-Term Investments	2.79	3.31	1.51	1.55	2.09
Cash & Short-Term Investments	4.38	5.93	2.12	2.12	2.79
Accounts Receivable	1.38	0.80	2.93	3.44	4.02
Inventory	1.39	1.14	0.98	1.52	1.18
Other Current Assets	0.08	0.00	0.00	0.00	0.00
Total Current Assets	7.43	8.05	6.02	7.15	7.99
Non-Current Assets
Property, Plant & Equipment (Net)	1.74	1.65	1.57	1.68	1.85
Long-Term Investments	1.27	1.70	1.15	0.75	0.28
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	3.00	3.35	2.72	2.42	0.00
Total Assets	10.43	11.40	8.74	9.57	10.12
Current Liabilities
Accounts Payable	1.50	1.40	1.86	2.01	3.17
Short-Term Debt	0.05	0.00	0.00	0.00	0.00
Deferred Revenue	0.10	0.00	0.02	0.08	0.00
Other Current Liabilities	0.38	0.18	0.13	0.10	0.10
Total Current Liabilities	1.95	1.63	2.00	2.33	3.37
Non-Current Liabilities
Long-Term Debt	0.16	0.10	0.04	0.04	0.00
Deferred Tax Liabilities	0.00	0.01	0.03	0.03	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.16	0.11	0.07	0.07	0.00
Total Liabilities	2.11	1.74	2.08	2.39	3.45
Stockholders' Equity
Common Stock	17.33	17.19	10.93	10.78	10.78
Retained Earnings	-3.44	-1.84	1.16	1.51	0.76
Accumulated Other Comprehensive Income	-0.56	-0.68	-5.42	-5.11	-4.88
Additional Paid-in Capital	-5.01	-5.01	-5.01	-5.01	0.00
Shares Outstanding	1.80	1.77	1.45	1.43	0.00
Total Stockholders' Equity	8.32	9.66	6.67	7.18	6.66
Total Liabilities & Equity	10.43	11.40	8.74	9.57	0.00